Literature DB >> 3746561

Schistosoma mansoni: production of cercarial eicosanoids as correlates of penetration and transformation.

A C Fusco, B Salafsky, K Delbrook.   

Abstract

A method was developed, using a 0.25% agar matrix, to incorporate varying concentrations of linoleate and correlate cercarial transformation and eicosanoid production in vitro. Schistosoma mansoni cercariae were stimulated to penetrate over a wide range of linoleate concentrations; however, the transformation process occurred over a narrow range. Approximately 25% of cercariae penetrated the agar matrix in controls (no linoleate) and 0.003 mM linoleate. Penetration rates rose gradually until, at linoleate concentrations of 0.3 mM or greater, penetration approached 100%. The transformation process did not begin until the linoleate concentration in agar reached 2.0 mM (3.8%), and achieved maximum (91%) at 3.0 mM. A concentration of 9.0 mM linoleate gave 100% penetration and transformation rates, but penetration was superficial and cercariae were not viable. Cercarial eicosanoid production was concentration-related. Various eicosanoid classes were associated with cercarial penetration and transformation. Penetration rates were correlated with increasing leukotriene (LT, R = 0.9541) and hydroxyeicosatetraenoic acid (HETE, R = 0.8363) levels, while transformation rates correlated with increasing prostaglandin levels (R = 0.9225). Correlating eicosanoid production with penetration and transformation rates strengthened the hypothesis that successful cercarial penetration and transformation are dependent on both skin essential fatty acid levels and resulting cercarial eicosanoid production.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3746561

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  9 in total

Review 1.  Modulation of the host's immune response by schistosome larvae.

Authors:  S J Jenkins; J P Hewitson; G R Jenkins; A P Mountford
Journal:  Parasite Immunol       Date:  2005 Oct-Nov       Impact factor: 2.280

Review 2.  Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes.

Authors:  Mairi C Noverr; John R Erb-Downward; Gary B Huffnagle
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

3.  Eicosanoid production by mouse peritoneal macrophages during Toxoplasma gondii penetration: role of parasite and host cell phospholipases.

Authors:  J F Thardin; C M'Rini; M Beraud; J Vandaele; M F Frisach; M H Bessieres; J P Seguela; B Pipy
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

4.  Characterization of Taenia solium cysticerci microsomal glutathione S-transferase activity.

Authors:  Gabriela Nava; Lilia Robert; Agustín Plancarte
Journal:  Parasitol Res       Date:  2007-08-18       Impact factor: 2.289

5.  Investigations into the production and function of leukotrienes during histotropic development of Oesophagostomum dentatum.

Authors:  A Daugschies
Journal:  Parasitol Res       Date:  1996       Impact factor: 2.289

6.  Identification of a novel prostaglandin f(2alpha) synthase in Trypanosoma brucei.

Authors:  B K Kubata; M Duszenko; Z Kabututu; M Rawer; A Szallies; K Fujimori; T Inui; T Nozaki; K Yamashita; T Horii; Y Urade; O Hayaishi
Journal:  J Exp Med       Date:  2000-11-06       Impact factor: 14.307

7.  Intravascular filarial parasites elaborate cyclooxygenase-derived eicosanoids.

Authors:  L X Liu; C N Serhan; P F Weller
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

8.  Density-Dependent Prophylaxis in Freshwater Snails Driven by Oxylipin Chemical Cues.

Authors:  Olwyn C Friesen; Chen-Hua Li; Ellen M E Sykes; Jake M Stout; Harold M Aukema; Ayush Kumar; Jillian T Detwiler
Journal:  Front Immunol       Date:  2022-01-31       Impact factor: 7.561

Review 9.  Role of leukotrienes on protozoan and helminth infections.

Authors:  Alexandre P Rogerio; Fernanda F Anibal
Journal:  Mediators Inflamm       Date:  2012-04-10       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.